Brightside Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 36)
Brightside Health logo

Brightside Health

EmergingHealthTech

Virtual Mental Health

Brightside Health provides virtual mental health treatment for anxiety and depression through a combined therapy, psychiatry, and medication management platform with insurance billing.

AI VisibilityBeta
Overall Score
D36
Category Rank
#525 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
31
Perplexity
32
Gemini
40

About

Brightside Health offers a fully virtual mental health platform that combines licensed therapist sessions, psychiatrist-prescribed medication management, and between-session digital support tools for adults with anxiety and depression. Unlike teletherapy-only platforms, Brightside's integrated care model allows therapists and prescribers on the same platform to coordinate treatment — particularly important for patients with moderate-to-severe symptoms who benefit from both therapy and pharmacotherapy.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

36
Overall Score
90
#525
Category Rank
#2
78
AI Consensus
83
stable
Trend
stable
31
ChatGPT
92
32
Perplexity
93
40
Gemini
89
34
Claude
96
36
Grok
95

Key Details

Category
Virtual Mental Health
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Brightside Health
Virtual Mental Health

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.